Skip to main content
search

Regulatory

Sign up

Latest resources

Featured resource

Upcoming regulatory webinars

Latest regulatory blogs

Meet our experts at the following events

Conference

EANM 2026

October 17 - 21, 2026 – Vienna, Austria
Conference

DIA Japan 2026

October 18 - 20, 2026 – Tokyo, Japan
Conference

AMWA 2026 Medical Writing & Communication Conference

November 4 - 7, 2026 – The Westin Washington, DC Downtown — 999 9th Street NW, Washington, DC

All regulatory resources

2nd Model-Informed Drug Development Summit

Certara Products, Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Therapeutic Specialties, Conference

From Data to Decisions: Getting More from Clinical Trial Evidence

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Webinar

How Do You Know You Have the Right Dose? Using Exposure-Response Evidence to Justify and Defend Dose Decisions

Certara Products, Certara Products - Phoenix, Certara Services, Clinical Pharmacology, Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Webinar

From Biological Mechanisms to Causal Inference: Quantitative Systems Pharmacology and Causal Frameworks in Drug Development

Modeling and Simulation - QSP, Publication

From Prediction to Decision Making: PBPK and QSP as Regulatory-Grade NAMs

Certara Products - Certara IQ, Certara Products - Simcyp, Infectious Disease, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Oncology/Hematology, Publication

From Excel to Enterprise: A Sponsor’s Journey to Modern Clinical Metadata Management

Certara Products - Pinnacle 21, Data Standards, Webinar

Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development

Certara Services, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), Publication

A glimpse into the future of model-informed drug discovery and development

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Oncology/Hematology, Pharmacometrics, Therapeutic Specialties, Publication

The five drug development questions that bring sponsors to pharmacometrics

Clinical Pharmacology, Drug Development, ICH M15, Model Informed Drug Development, Modeling and Simulation, Pharmacometrics, Blog

Model-Based Meta-Analysis (MBMA): Real-World Examples

Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation - MBMA, Fact Sheet

A model-informed approach to radioligand therapy dosing under Project Optimus

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Therapeutic Specialties, Blog

Investor panel: What it takes to build a fundable biotech – with Life Science Nation

Certara Services, Drug Development, Model Informed Drug Development, On-Demand Webinar
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.